Pharmacovigilance: ``Vigilantia initiative''

Article type: Research Article

Authors: Trujillo, Juan Carlos | De Guzman, Ma. Alejandra^*

Affiliations: Bogota, Colombia

Correspondence: [*] Corresponding author: Ma. Alejandra De Guzman, Bogota, Colombia. Tel.: +57 30435460983; E-mail:[email protected]

Abstract: Every day Pharmacovigilance becomes increasingly important to patient health. There are some gaps and limitations in the current Latin American Pharmacovigilance framework which could be addressed to have a better system to correctly and promptly identify suspected adverse drug reactions (ADR). Considering this context, Vigilantia was born as an initiative to foster Pharmacovigilance both scientifically and educationally, and enhance all aspects of the safe and proper use of medicines, across all Latin America.

Keywords: Pharmacovigilance, patient safety, Vigilantia, adverse drug reaction (ADR)

DOI: 10.3233/PPL-160440

Journal: Pharmaceuticals Policy and Law, vol. 18, no. 1-4, pp. 157-162, 2016